亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)鹽酸洛哌丁胺原料藥生產(chǎn)廠家供應(yīng)

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
品牌 武漢大華
過(guò)期 長(zhǎng)期有效
更新 2012-10-23 14:32
 

武漢大華偉業(yè)醫(yī)藥化工公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

產(chǎn)品名稱:鹽酸洛哌丁胺

英文名稱:Loperamide hydrochloride

化學(xué)名稱:4-(對(duì)氯苯基)-4-羥基-N,N-二甲基-alpha,alpha-二苯基-1-哌啶丁酰胺鹽酸鹽

分 子 式:C29H33ClN2O2.HCl

分 子 量:513.50

質(zhì)量標(biāo)準(zhǔn):USP32  含量:99%) 

CAS 號(hào) :34552-83-5

外 觀:白色結(jié)晶

含 量:98-102%

熔 點(diǎn):222-223℃

干燥失重:≤0.5%

灼燒殘?jiān)?le;0.2%

重 金 屬:≤0.002%

鹽酸洛哌丁胺是一種白色或類白色的結(jié)晶性粉末,可以作為止瀉藥,或者是長(zhǎng)效抗腹瀉藥物,多用于治療急、慢性痢疾。服用過(guò)量時(shí),可能出現(xiàn)嗜睡、便秘、肌肉緊張、瞳孔縮小、呼吸徐緩等中毒癥狀,可用納洛酮解毒,并對(duì)患者進(jìn)行至少48小時(shí)的觀察,以便及時(shí)發(fā)現(xiàn)中樞神經(jīng)系統(tǒng)的抑制作用。

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)氨茶堿原料廠家供應(yīng) 供應(yīng)溶菌酶原料藥廠家供應(yīng) 供應(yīng)磺胺嘧啶銀原料藥廠家供應(yīng) 供應(yīng)鹽酸苯海拉明原料藥廠家供應(yīng) 供應(yīng)L-鳥氨酸鹽酸鹽廠家供應(yīng) 供應(yīng)四磷酸腺二鳥苷原料藥-生產(chǎn)廠家供應(yīng) 供應(yīng)氯雷他定原料藥廠家供應(yīng) 供應(yīng)D-泛酸鈣廠家價(jià)格
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |